| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| SNY | Sanofi | $42.07 | $104.22B | Uptrend |
Biechele Royce Advisors Buys Procter & Gamble Co, Franklin Resources Inc, Sanofi SA, Sells ...
http://www.gurufocus.com/news/710686/biechele-royce-advisors-buys-procter--gamble-co-franklin-resources-inc-sanofi-sa-sells-schlumberger-total-sa-patterson-inc
Jul 20, 2018 - Biechele Royce Advisors Buys Procter & Gamble Co, Franklin Resources Inc, Sanofi SA, Sells Schlumberger, Total SA, Patterson Inc, Stocks: PG,SNY,UNP,SBUX,GLD,UPS,BEN,EPD,SLB,TOT,PDCO,MOS,, release date:Jul 20, 2018
0
6 European Stocks to Shun on Tapered IMF Outlook
http://www.zacks.com/stock/news/312147/6-european-stocks-to-shun-on-tapered-imf-outlook?cid=CS-ZC-FT-312147
Jul 19, 2018 - IMF lowered its growth projection for in Germany, France and Italy. Time to avoid these sell-ranked stocks?
0
Aquestive Therapeutics Readies $60 Million IPO
https://seekingalpha.com/article/4187487-aquestive-therapeutics-readies-60-million-ipo?source=feed_tag_ipo_analysis
Jul 16, 2018 - Aquestive Therapeutics has filed amended terms for its $60 million U.S. IPO.The firm combines a manufacturing operation with a more recent development pipeline.AQST is pursuing an intriguing business
0
Constellation Pharmaceuticals Readies $80 Million IPO Plans
https://seekingalpha.com/article/4186954-constellation-pharmaceuticals-readies-80-million-ipo-plans?source=feed_tag_ipo_analysis
Jul 12, 2018 - Constellation Pharmaceuticals intends to sell $80 million of its common stock in a U.S. IPO.The firm is developing treatment candidates for a variety of cancers and myelofibrosis diseases.CNST has sho
0
A Wormhole View Of Voyager's Parkinson's Gene Therapy
https://seekingalpha.com/article/4186427-wormhole-view-voyagers-parkinsons-gene-therapy?source=feed_sector_healthcare
Jul 10, 2018 - The initial phase 1 trial results were comparable to several prior Parkinson's therapies that weren't approved. A large percentage of patients opted to undergo deep brain stimulation surgery relativel
0
Seth Klarman Declares Ownership of Fledgling Biotech
http://www.gurufocus.com/news/706095/seth-klarman-declares-ownership-of-fledgling-biotech
Jul 10, 2018 - Seth Klarman Declares Ownership of Fledgling Biotech, Stocks: TBIO,SNY, release date:Jul 10, 2018
0
Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori's Mixed ED Data
https://seekingalpha.com/article/4186242-biotech-analysis-central-pharma-news-catabasis-nears-phase-3-start-regulus-slashes-workforce?source=feed_sector_healthcare
Jul 10, 2018 - Catabasis will soon launch a phase 3 study treating patients with DMD.Regulus Therapeutics pauses clinical studies and slashes 60% of workforce.Cytori Therapeutics announces phase 1 results for erecti
0
Learn How To Invest Against Acute Myeloid Leukemia, One Of The Fastest-Growing Cancer Markets
https://seekingalpha.com/article/4185915-learn-invest-acute-myeloid-leukemia-one-fastest-growing-cancer-markets?source=feed_all_articles
Jul 09, 2018 - Acute myeloid leukemia is the subject of major research and development.Investors interested in cancer should definitely be aware of AML and the ongoing developments.This article focuses on the basics
0
Regulus Stock Plunges on Cash Concerns Despite Restructuring
http://www.zacks.com/stock/news/310672/regulus-stock-plunges-on-cash-concerns-despite-restructuring?cid=CS-ZC-FT-310672
Jul 09, 2018 - Regulus Therapeutics (RGLS) announces strategic and restructuring plans to extend cash runway. However, investors remain skeptical.
0
Week In Review: Suzhou Innovent Files For HK IPO - $500 Million Raise Rumored
https://seekingalpha.com/article/4185917-week-review-suzhou-innovent-files-hk-ipo-500-million-raise-rumored?source=feed_all_articles
Jul 08, 2018 - Deals and Financings Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, accordi
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| GSK | GlaxoSmithKline PLC | NYSE | $40.97 | $101.6B |
| LLY | Eli Lilly and Company | NYSE | $90.03 | $97.72B |
| ABT | Abbott Laboratories | NYSE | $64.75 | $113.52B |
| AZN | Astrazeneca PLC | NYSE | $37.33 | $94.57B |
| BMY | Bristol-Myers Squibb Company | NYSE | $56.88 | $92.97B |
SNY - Nasdaq
http://www.nasdaq.com/symbol/sny
Quote information directly from the exchange
SEC filings
Comparison
Ownership
Insiders
Institutions
Revenue/EPS
Competitors
Guru
Report
Analysts
Pre-market
Quote
Consultant
After hours
Transcripts
SNY - Google Finance
https://www.google.com/finance?q=SNY
Industry related info and international coverage
Summary
News
SNY - Bloomberg
http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=SNY
Original news and commentary from Bloomberg
Charts
Financials with pensions
Snapshot
Earnings
Transactions
People
Options